论文部分内容阅读
2007年牛气冲天的中国股市进入2008年来了个急转弯,一下子跌入了熊市。虽然如此,但如果股民选对了股,相信还是会取得不错的投资收益。关键看你是否独具慧眼。医药板块拥有100多支股票,是近几年交易比较活跃的板块,理所当然地吸引了股民们关注的目光。医药板块风水如何呢?在当前的情况下,医药股能不能买?有的人认为可以买,因为上市药企的产品销售状况良好,经营业绩也普遍不错,企业资产优良,从长远来看,医药股会给投资者带来满意的收益。因而,当前买医药股恰逢其时。有的人则认为当前买医药股并非明智的选择,随着国家不断下调药价以及即将推出的并不利于药企的医改政策,上市药企的利润将不可避免地大幅度缩水,其发展的前景并不乐观。那么,股民到底该不该买医药股呢?本期辩论会邀请了相关的学者和资深股评家展开辩论。
Chinese bull market in 2007 came to a sharp turn in 2008, suddenly fell into a bear market. Nevertheless, but if the shareholders voted on the stock, I believe will still get a good return on investment. The key to see if you are unique insight. With more than 100 stocks in the pharmaceutical sector, it is the most actively traded segment in recent years, which has naturally attracted the attention of investors. In the current situation, the pharmaceutical stocks can buy? Some people think that you can buy because the listed pharmaceutical companies good product sales, business performance is generally good, corporate assets are good, in the long run, Pharmaceutical stocks will give investors a satisfactory return. Thus, the current medical stocks to buy the right time. Some people think that the current purchase of pharmaceutical stocks is not a wise choice, as countries continue to cut drug prices and the forthcoming policy reform is not conducive to pharmaceutical companies, the profits of listed pharmaceutical companies will inevitably be substantially reduced, its development The outlook is not optimistic. So, investors in the end should not buy pharmaceutical stocks it? This debate will invite the relevant scholars and senior stock analysts to debate.